{"data":[{"accessionNo":"0001440771-26-000020","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares","eventDate":"2026-08-20","reportingPerson":"Stonepine Capital, L.P.","reportingCik":null,"personType":"PN","sharesOwned":953739,"percentOfClass":6.9,"filedAt":"2026-08-26","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001440771-26-000020","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares","eventDate":"2026-08-20","reportingPerson":"Stonepine GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":953739,"percentOfClass":6.9,"filedAt":"2026-08-26","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001440771-26-000020","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares","eventDate":"2026-08-20","reportingPerson":"Stonepine Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":953739,"percentOfClass":6.9,"filedAt":"2026-08-26","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001440771-26-000020","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares","eventDate":"2026-08-20","reportingPerson":"Jon M. Plexico","reportingCik":null,"personType":"HC,IN","sharesOwned":953739,"percentOfClass":6.9,"filedAt":"2026-08-26","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-005738","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, no par value per share","eventDate":"2026-08-21","reportingPerson":"Pardeep Nijhawan","reportingCik":"0001777962","personType":"IN","sharesOwned":2613492,"percentOfClass":16.31,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-002310","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-08-21","reportingPerson":"Velan Capital Management LLC","reportingCik":"0001964355","personType":"OO","sharesOwned":1356455,"percentOfClass":9.99,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-002310","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-08-21","reportingPerson":"VENKATARAMAN BALAJI","reportingCik":"0001114916","personType":"IN","sharesOwned":1356455,"percentOfClass":9.99,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-002310","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-08-21","reportingPerson":"Morgan Adam","reportingCik":"0001964335","personType":"IN","sharesOwned":1356455,"percentOfClass":9.99,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-002310","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-08-21","reportingPerson":"Velan Capital Investment Management LP","reportingCik":"0001848809","personType":"IA,PN","sharesOwned":1356455,"percentOfClass":9.99,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-002310","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-08-21","reportingPerson":"Velan Capital Holdings LLC","reportingCik":"0001964353","personType":"OO","sharesOwned":1331385,"percentOfClass":9.8,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-002310","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-08-21","reportingPerson":"Velan Capital Master Fund LP","reportingCik":"0001964356","personType":"PN","sharesOwned":1081385,"percentOfClass":8,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-005738","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, no par value per share","eventDate":"2026-08-21","reportingPerson":"Pardeep Nijhawan Medicine Professional Corporation","reportingCik":null,"personType":"CO","sharesOwned":1164676,"percentOfClass":7.8,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-002310","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-08-21","reportingPerson":"Velan Capital Opportunity Fund II LLC","reportingCik":"0002057744","personType":"OO","sharesOwned":250000,"percentOfClass":1.9,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-005738","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, no par value per share","eventDate":"2026-08-21","reportingPerson":"1968160 Ontario Inc.","reportingCik":null,"personType":"CO","sharesOwned":53104,"percentOfClass":0.4,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-002310","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-08-21","reportingPerson":"Velan Horizon Fund LP","reportingCik":"0002057740","personType":"PN","sharesOwned":25070,"percentOfClass":0.2,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-005738","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, no par value per share","eventDate":"2026-08-21","reportingPerson":"The Digestive Health Clinic Inc.","reportingCik":null,"personType":"CO","sharesOwned":32013,"percentOfClass":0.2,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-002310","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-08-21","reportingPerson":"Velan Horizon GP LLC","reportingCik":"0002057821","personType":"OO","sharesOwned":25070,"percentOfClass":0.2,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-005738","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, no par value per share","eventDate":"2026-08-21","reportingPerson":"The New Nijhawan Family Trust 2015","reportingCik":null,"personType":"OO","sharesOwned":32609,"percentOfClass":0.2,"filedAt":"2026-08-25","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001104659-26-075834","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-06-11","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":520685,"percentOfClass":5.4,"filedAt":"2026-06-18","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001104659-26-075834","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-06-11","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":520685,"percentOfClass":5.4,"filedAt":"2026-06-18","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001104659-26-075834","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-06-11","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":520685,"percentOfClass":5.4,"filedAt":"2026-06-18","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001104659-26-075834","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-06-11","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":520685,"percentOfClass":5.4,"filedAt":"2026-06-18","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-004153","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, no par value per share","eventDate":"2026-06-16","reportingPerson":"Pardeep Nijhawan","reportingCik":"0001777962","personType":"IN","sharesOwned":2210022,"percentOfClass":19.99,"filedAt":"2026-06-16","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-004153","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, no par value per share","eventDate":"2026-06-16","reportingPerson":"Pardeep Nijhawan Medicine Professional Corporation","reportingCik":null,"personType":"CO","sharesOwned":1164676,"percentOfClass":11.2,"filedAt":"2026-06-16","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-004153","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, no par value per share","eventDate":"2026-06-16","reportingPerson":"1968160 Ontario Inc.","reportingCik":null,"personType":"CO","sharesOwned":53104,"percentOfClass":0.6,"filedAt":"2026-06-16","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-004153","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, no par value per share","eventDate":"2026-06-16","reportingPerson":"The New Nijhawan Family Trust 2015","reportingCik":null,"personType":"OO","sharesOwned":32609,"percentOfClass":0.3,"filedAt":"2026-06-16","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-004153","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, no par value per share","eventDate":"2026-06-16","reportingPerson":"The Digestive Health Clinic Inc.","reportingCik":null,"personType":"CO","sharesOwned":32013,"percentOfClass":0.3,"filedAt":"2026-06-16","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001104659-26-062476","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, no par value","eventDate":"2025-03-31","reportingPerson":"David Rosen","reportingCik":null,"personType":"HC,IN","sharesOwned":687500,"percentOfClass":7.74,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001104659-26-062476","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, no par value","eventDate":"2025-03-31","reportingPerson":"Rubric Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":687500,"percentOfClass":7.74,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000919574-26-003220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-03-31","reportingPerson":"Sirenia Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":600000,"percentOfClass":7.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000919574-26-003220","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-03-31","reportingPerson":"Alex Silverstein","reportingCik":null,"personType":"HC,IN","sharesOwned":600000,"percentOfClass":7.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000935836-26-000278","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Stonepine GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":30000,"percentOfClass":0.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000935836-26-000278","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Stonepine Capital, L.P.","reportingCik":null,"personType":"PN","sharesOwned":30000,"percentOfClass":0.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000935836-26-000278","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Stonepine Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":30000,"percentOfClass":0.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000935836-26-000278","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Jon M. Plexico","reportingCik":null,"personType":"HC,IN","sharesOwned":30000,"percentOfClass":0.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001104659-26-062705","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-03-31","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000919574-26-003493","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-03-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":2,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000919574-26-003493","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-03-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":2,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000919574-26-003493","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-03-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001104659-26-062705","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-03-31","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001104659-26-062705","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-03-31","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001193125-26-108289","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-03-09","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":563239,"percentOfClass":6.7,"filedAt":"2026-03-16","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001193125-26-108289","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-03-09","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":563239,"percentOfClass":6.7,"filedAt":"2026-03-16","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001193125-26-108289","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":"27966L306","securityClass":"Common Shares, without par value","eventDate":"2026-03-09","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":563239,"percentOfClass":6.7,"filedAt":"2026-03-16","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000902664-26-001400","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2026-02-24","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":600000,"percentOfClass":7.2,"filedAt":"2026-03-03","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000902664-26-001400","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2026-02-24","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":600000,"percentOfClass":7.2,"filedAt":"2026-03-03","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000902664-26-001400","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2026-02-24","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":600000,"percentOfClass":7.2,"filedAt":"2026-03-03","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-001269","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-26","reportingPerson":"Pardeep Nijhawan","reportingCik":"0001777962","personType":"IN","sharesOwned":2040785,"percentOfClass":19.99,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-001269","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-26","reportingPerson":"Pardeep Nijhawan Medicine Professional Corporation","reportingCik":null,"personType":"CO","sharesOwned":1133676,"percentOfClass":11.9,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-000578","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2026-02-26","reportingPerson":"Velan Capital Investment Management LP","reportingCik":"0001848809","personType":"IA,PN","sharesOwned":834700,"percentOfClass":9.99,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-000578","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2026-02-26","reportingPerson":"Velan Capital Management LLC","reportingCik":"0001964355","personType":"OO","sharesOwned":834700,"percentOfClass":9.99,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-000578","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2026-02-26","reportingPerson":"Morgan Adam","reportingCik":"0001964335","personType":"IN","sharesOwned":834700,"percentOfClass":9.99,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-000578","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2026-02-26","reportingPerson":"VENKATARAMAN BALAJI","reportingCik":"0001114916","personType":"IN","sharesOwned":834700,"percentOfClass":9.99,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-000578","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2026-02-26","reportingPerson":"Velan Capital Holdings LLC","reportingCik":"0001964353","personType":"OO","sharesOwned":819075,"percentOfClass":9.8,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-000578","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2026-02-26","reportingPerson":"Velan Capital Master Fund LP","reportingCik":"0001964356","personType":"PN","sharesOwned":569075,"percentOfClass":6.8,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-000578","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2026-02-26","reportingPerson":"Velan Capital Opportunity Fund II LLC","reportingCik":"0002057744","personType":"OO","sharesOwned":250000,"percentOfClass":3,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-001269","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-26","reportingPerson":"1968160 Ontario Inc.","reportingCik":null,"personType":"CO","sharesOwned":53104,"percentOfClass":0.6,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-001269","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-26","reportingPerson":"The New Nijhawan Family Trust 2015","reportingCik":null,"personType":"OO","sharesOwned":32609,"percentOfClass":0.4,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001171843-26-001269","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, no par value per share","eventDate":"2026-02-26","reportingPerson":"The Digestive Health Clinic Inc.","reportingCik":null,"personType":"CO","sharesOwned":32013,"percentOfClass":0.4,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-000578","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2026-02-26","reportingPerson":"Velan Horizon Fund LP","reportingCik":"0002057740","personType":"PN","sharesOwned":15625,"percentOfClass":0.2,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0000921895-26-000578","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"Edesa Biotech, Inc.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2026-02-26","reportingPerson":"Velan Horizon GP LLC","reportingCik":"0002057821","personType":"OO","sharesOwned":15625,"percentOfClass":0.2,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001104659-26-015335","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2025-12-31","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":855583,"percentOfClass":9.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001104659-26-015335","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2025-12-31","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":855583,"percentOfClass":9.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"},{"accessionNo":"0001104659-26-015335","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001540159","issuerName":"EDESA BIOTECH, INC.","ticker":"EDSA","cusip":null,"securityClass":"Common Shares, without par value","eventDate":"2025-12-31","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":855583,"percentOfClass":9.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/edsa"}],"updatedAt":"2026-10-24T18:28:29.447Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/edsa","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}